logo

Selecta Biosciences Inc. (SELB)



Trade SELB now with
  Date
  Headline
3/12/2018 8:05:58 AM Selecta Biosciences: First Patient Dosed In Phase 1 Trial Of SEL-403 In Mesothelioma
1/2/2018 8:17:13 AM Selecta Biosciences President And CEO Werner Cautreels Intends To Retire Effective December 31, 2018
1/2/2018 8:06:34 AM Selecta Announces FDA Acceptance Of Investigational NDA For LMB-100 And SVP-Rapamycin Combination Therapy
  
 
>